Amundi Sells 639,405 Shares of Henry Schein, Inc. $HSIC

Key Points

• Amundi significantly reduced its stake in Henry Schein, Inc. by 86.8%, selling 639,405 shares and maintaining only 97,232 shares valued at approximately $6.5 million.
• Several institutional investors, including JPMorgan Chase & Co. and Burgundy Asset Management Ltd., increased their holdings in Henry Schein during the same quarter, reflecting varied investor sentiment.
• Henry Schein recently reported earnings per share of $1.10 for the quarter, which missed analyst expectations, while also providing fiscal year guidance of 4.800-4.940 EPS for FY 2025.

Amundi decreased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 86.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,232 shares of the company's stock after selling 639,405 shares during the quarter. Amundi owned approximately 0.08% of Henry Schein worth $6,475,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. lifted its holdings in Henry Schein by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock valued at $436,489,000 after buying an additional 390,399 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Henry Schein by 4.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company's stock valued at $153,480,000 after purchasing an additional 103,384 shares in the last quarter. Burgundy Asset Management Ltd. raised its holdings in shares of Henry Schein by 33.9% in the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company's stock valued at $153,105,000 after purchasing an additional 566,530 shares in the last quarter. Clarkston Capital Partners LLC raised its holdings in shares of Henry Schein by 0.4% in the 1st quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company's stock valued at $119,965,000 after purchasing an additional 7,345 shares in the last quarter. Finally, Steadfast Capital Management LP raised its holdings in shares of Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock valued at $113,336,000 after purchasing an additional 1,175,408 shares in the last quarter. Institutional investors own 96.62% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on HSIC. Leerink Partners set a $75.00 price target on shares of Henry Schein in a report on Monday, July 14th. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Robert W. Baird restated a "neutral" rating and issued a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Stifel Nicolaus restated a "hold" rating and issued a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Down 0.4%

HSIC stock opened at $67.41 on Thursday. The firm's fifty day simple moving average is $69.54 and its 200-day simple moving average is $69.59. The company has a market capitalization of $8.17 billion, a P/E ratio of 21.75, a price-to-earnings-growth ratio of 2.23 and a beta of 0.86. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm's quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.